Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Omaha, Nebraska 68154


Purpose:

The purpose of the study is to evaluate the safety and efficacy of new tablet formulations of Premarin®/medroxyprogesterone (MPA).


Criteria:

- Healthy postmenopausal women aged 35 to 70 years with spontaneous or surgical amenorrhea - BMI in the range of 18 to 35 kg/m2 - History or presence of hypertension (>139 mm Hg systolic or >89 mm Hg diastolic) - History of drug allergy, particularly to conjugated estrogens (CE) or selective estrogen receptor modulators (SERMs) - Use of any prescription or investigational drug within 30 days before test article administration


NCT ID:

NCT00543634


Primary Contact:

Study Director
Pfizer CT.gov Call Center
Wyeth


Backup Contact:

N/A


Location Contact:

Omaha, Nebraska 68154
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: August 17, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.